Qualitative evaluation of the implementation and national roll-out of the NHS App in England.

IF 7 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL BMC Medicine Pub Date : 2025-01-21 DOI:10.1186/s12916-024-03842-w
Claire Reidy, Chrysanthi Papoutsi, Sukriti Kc, Bernard Gudgin, Anthony A Laverty, Felix Greaves, John Powell
{"title":"Qualitative evaluation of the implementation and national roll-out of the NHS App in England.","authors":"Claire Reidy, Chrysanthi Papoutsi, Sukriti Kc, Bernard Gudgin, Anthony A Laverty, Felix Greaves, John Powell","doi":"10.1186/s12916-024-03842-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The NHS App launched in 2019 as the 'digital front door' to the National Health Service in England with core features including General Practitioner (GP) appointment booking, repeat prescriptions, patient access to records and, later on, COVID-19 vaccination certification. Similar patient portals have been adopted in different formats and with variable levels of success. In this longitudinal study (2021-2023) we examined how the NHS App became implemented in the pandemic context and beyond.</p><p><strong>Methods: </strong>We recruited 88 participants in 62 qualitative interviews and four focus groups. Participants included patients, carers, members of the public, clinical/non-clinical NHS staff from five GP practices (where we also conducted over 60 h of observations) across England, as well as other industry, policy and civil rights stakeholders. Document analysis also contributed to participant recruitment and data interpretation. Data collection and analysis was informed by the Non-Adoption, Abandonment, Scale-up, Spread and Sustainability (NASSS) framework.</p><p><strong>Results: </strong>Our study identified the various ways in which complexity manifested as part of the implementation, use and roll-out of the NHS App. Patients had diverse (positive and negative) user experiences as the app evolved, with some of its features described as more useful than others (e.g. prescription ordering, COVID Pass). As the app primarily provided a gateway to general practice systems and infrastructures, not all features were available by default or consistently to all users, with information often appearing fragmented or system-facing (e.g. coded). NHS staff viewed the app as constituting core NHS infrastructure in the long term which made it appealing, even though initially there was less recognition of its immediate value. There was variable organisational capacity to enable implementation and to put in place processes and staff roles required to support patient adoption. Shifting emphasis towards in-person care, challenges with digital inclusion and controversies related to features such as patient access to own records further complicated roll-out.</p><p><strong>Conclusions: </strong>As the NHS App remains a complex innovation in a shifting landscape, it is clear ongoing work is needed to ensure its potential can be sustained to meet patient, service and policy needs.</p><p><strong>Clinical study registration: </strong>ISRCTN72729780.</p>","PeriodicalId":9188,"journal":{"name":"BMC Medicine","volume":"23 1","pages":"20"},"PeriodicalIF":7.0000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11752663/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12916-024-03842-w","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The NHS App launched in 2019 as the 'digital front door' to the National Health Service in England with core features including General Practitioner (GP) appointment booking, repeat prescriptions, patient access to records and, later on, COVID-19 vaccination certification. Similar patient portals have been adopted in different formats and with variable levels of success. In this longitudinal study (2021-2023) we examined how the NHS App became implemented in the pandemic context and beyond.

Methods: We recruited 88 participants in 62 qualitative interviews and four focus groups. Participants included patients, carers, members of the public, clinical/non-clinical NHS staff from five GP practices (where we also conducted over 60 h of observations) across England, as well as other industry, policy and civil rights stakeholders. Document analysis also contributed to participant recruitment and data interpretation. Data collection and analysis was informed by the Non-Adoption, Abandonment, Scale-up, Spread and Sustainability (NASSS) framework.

Results: Our study identified the various ways in which complexity manifested as part of the implementation, use and roll-out of the NHS App. Patients had diverse (positive and negative) user experiences as the app evolved, with some of its features described as more useful than others (e.g. prescription ordering, COVID Pass). As the app primarily provided a gateway to general practice systems and infrastructures, not all features were available by default or consistently to all users, with information often appearing fragmented or system-facing (e.g. coded). NHS staff viewed the app as constituting core NHS infrastructure in the long term which made it appealing, even though initially there was less recognition of its immediate value. There was variable organisational capacity to enable implementation and to put in place processes and staff roles required to support patient adoption. Shifting emphasis towards in-person care, challenges with digital inclusion and controversies related to features such as patient access to own records further complicated roll-out.

Conclusions: As the NHS App remains a complex innovation in a shifting landscape, it is clear ongoing work is needed to ensure its potential can be sustained to meet patient, service and policy needs.

Clinical study registration: ISRCTN72729780.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对英格兰NHS应用程序的实施和全国推广进行定性评估。
背景:NHS应用程序于2019年推出,是英国国家卫生服务的“数字前门”,其核心功能包括全科医生预约、重复处方、患者访问记录,以及后来的COVID-19疫苗接种认证。类似的病人门户网站以不同的形式被采用,取得了不同程度的成功。在这项纵向研究(2021-2023)中,我们研究了NHS应用程序是如何在大流行背景下实施的。方法:采用62次定性访谈和4个焦点小组,共招募88名参与者。参与者包括患者,护理人员,公众成员,来自英格兰五家全科医生诊所的临床/非临床NHS工作人员(我们也在那里进行了超过60小时的观察),以及其他行业,政策和民权利益相关者。文献分析也有助于参与者招募和数据解释。数据收集和分析由“不采用、放弃、扩大规模、传播和可持续性”(NASSS)框架提供信息。结果:我们的研究确定了复杂性在NHS应用程序的实施、使用和推出过程中表现出来的各种方式。随着应用程序的发展,患者有不同的(积极和消极的)用户体验,其中一些功能被描述为比其他功能更有用(例如处方订购、COVID Pass)。由于应用程序主要提供了通往全科实践系统和基础设施的门户,并非所有功能都默认或一致地对所有用户可用,信息通常是碎片化的或面向系统的(例如编码)。NHS的工作人员认为,从长远来看,这款应用程序构成了NHS的核心基础设施,这使得它很有吸引力,尽管最初人们对它的直接价值认识较少。有可变的组织能力,使实施和到位的过程和工作人员的角色,需要支持病人的收养。将重点转向面对面护理,数字包容的挑战以及与患者访问自己的记录等功能相关的争议进一步复杂化了推出。结论:由于NHS应用程序在不断变化的环境中仍然是一项复杂的创新,显然需要进行持续的工作,以确保其潜力能够持续满足患者,服务和政策需求。临床研究注册:ISRCTN72729780。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Medicine
BMC Medicine 医学-医学:内科
CiteScore
13.10
自引率
1.10%
发文量
435
审稿时长
4-8 weeks
期刊介绍: BMC Medicine is an open access, transparent peer-reviewed general medical journal. It is the flagship journal of the BMC series and publishes outstanding and influential research in various areas including clinical practice, translational medicine, medical and health advances, public health, global health, policy, and general topics of interest to the biomedical and sociomedical professional communities. In addition to research articles, the journal also publishes stimulating debates, reviews, unique forum articles, and concise tutorials. All articles published in BMC Medicine are included in various databases such as Biological Abstracts, BIOSIS, CAS, Citebase, Current contents, DOAJ, Embase, MEDLINE, PubMed, Science Citation Index Expanded, OAIster, SCImago, Scopus, SOCOLAR, and Zetoc.
期刊最新文献
Bridging animal models and humans: neuroimaging as intermediate phenotypes linking genetic or stress factors to anhedonia. Development a glycosylated extracellular vesicle-derived miRNA Signature for early detection of esophageal squamous cell carcinoma. Performance of the 2023 diagnostic criteria for MOGAD: real-world application in a Chinese multicenter cohort of pediatric and adult patients. Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting. Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1